| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 769,619 | 683,770 | 779,665 | 911,173 | | Cost of Revenue | 420,776 | 357,381 | 430,842 | 495,288 | | | Gross Profit | 348,843 | 326,389 | 348,823 | 415,885 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 408,509 | 387,101 | 425,029 | 448,683 | | Non Recurring |
-
| 887 | 1,898 | 683,071 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (59,666) | (61,599) | (78,104) | (715,869) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10,097) | (7,287) | 5,913 | (3,749) | | Earnings Before Interest And Taxes | (116,625) | (68,886) | (72,191) | (719,618) | | Interest Expense | (29,452) | 15,570 | 13,882 | 14,366 | | Income Before Tax | (87,173) | (84,456) | (86,073) | (733,984) | | Income Tax Expense | 621 | (7,711) | 1,260 | 48,567 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (87,794) | (76,745) | (87,333) | (782,551) | | | Non-recurring Events | | Discontinued Operations | (2,918) | (5,375) | (4,415) | (46,351) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (90,158) | (82,120) | (91,748) | (828,902) | | Preferred Stock And Other Adjustments | (383) | 14 | 369 |
-
| | | Net Income Applicable To Common Shares | ($90,541) | ($82,106) | ($91,379) | ($828,902) |
|
0.20% Nasdaq 
0.14%
Income Statement
